Moderna

Moderna is one of the...

• Forbes Global 2000 (#463);
• Fortune 500 (#211);
• Nasdaq 100;
• Russell 3000;
• S&P 500.

Moderna is a company listed under the stock ticker MRNA (US).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 64 main executives

Most searched biographies at Moderna

• Stéphane Bancel, Director, President and Founding Chief Executive...
• Robert Langer, Board Member
• Francois Nader, Director

Create your alert
to follow the executive moves at Moderna.

Moderna has 1,882 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• Novo Holdings has announced the acquisition of Paratek Pharmaceuticals  (posted on September 27 2023).
• Generate Biomedicines has just announced a $273 Million fundraising (posted on September 19 2023).
• Harmony Biosciences has announced the acquisition of Zynerba Pharmaceuticals  (posted on August 15 2023).

Popular contacts in Pharmaceuticals

• Kristin Peck - Chief Executive Officer and Director at Zoetis
• Danilo Cicmil - Supervisory Board Member at Galenika
• Lionel Viret - Chairman of the Board at Groupe Stago

Learn more about the Pharmaceuticals industry >

Press releases by Moderna

• R&D Day Reflections with CFO Jamey Mock
• EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union
• Our Continued Innovation at Work: Celebrating U.S. FDA Approval of Our Updated COVID-19 Vaccine
• Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
• Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine
• Moderna Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
• Moderna to Participate at Morgan Stanley 21st Annual Global Healthcare Conference
• Moderna Clinical Trial Data Confirm Its Updated Covid-19 Vaccine Generates Strong Immune Response in Humans Against BA.2.86
• 3 Things to Know About the 2023-2024 COVID-19 Season
• Moderna to Host Investor Event - R&D Day and Business Updates
• View more press releases Close

Social media about Moderna

• Moderna on Wikipedia, Google News & Yahoo Finance
• Moderna on LinkedIn, Twitter & YouTube

Contact by email its executives including Stéphane Bancel

Call Moderna at +1 617...

View the org chart

Register to receive your alert

Report an error